Your medical briefing

Stay current.
Stay focused.

Research, guidelines, and safety alerts for your specialty.

Toxicology

Recent updates in Toxicology from the last 30 days.

AllAll updates Research Guidelines Safety alerts

A systematic review and meta-analysis of seven randomized controlled trials (421 patients) evaluated fresh frozen plasma added to standard atropine/oxime therapy for acute organophosphate poisoning. The pooled analysis reported no statistically significant reduction in mortality, though it found a shorter hospital stay and reduced need for mechanical ventilation with FFP; the authors rated the certainty of evidence as low to very low. The authors concluded that current evidence is insufficient to support routine use of FFP and called for larger, higher-quality trials.

Stay current.
Stay focused.

Toxicology

Meta-analysis finds no mortality benefit from adjunctive FFP in OP poisoning

Rush physicians report rising 7-OH addiction and emergency cases

Case series links mushroom toxin to reversible acute kidney injury

ToxIC report describes cychlorphine, a new non-fentanyl synthetic opioid

Class I recall: Baxter Healthcare Corporation: Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporat

Class II recall: Baxter Healthcare Corporation: Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/m

Class II recall: Baxter Healthcare Corporation: Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in G

Class II recall: Mylan Pharmaceuticals Inc: Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured f

Class I recall: OPTIMAL BALANCE PHARMACY: Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutath

Class I recall: Baxter Healthcare Corporation: 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 u

Class II recall: Baxter Healthcare Corporation: Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Sin

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx On

Class II recall: Hikma Pharmaceuticals USA INC.: Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bot

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Onl

Class II recall: Mallinckrodt Hospital Products Inc.: Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Onl

Class I recall: Fresenius Kabi USA, LLC: Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Onl

Stay current. Stay focused.

Stay current.
Stay focused.